{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:02:13Z","timestamp":1790654533784,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.pbb.2023.173659","type":"journal-article","created":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T10:53:24Z","timestamp":1697280804000},"page":"173659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Prophylactic effects of arketamine, but not hallucinogenic psychedelic DOI nor non-hallucinogenic psychedelic analog lisuride, in lipopolysaccharide-treated mice and mice exposed to chronic restrain stress"],"prefix":"10.1016","volume":"233","author":[{"given":"Guilin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youge","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiayun","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumi","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.pbb.2023.173659_bb0005","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1038\/s41380-021-01093-2","article-title":"Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability","volume":"26","author":"Bonaventura","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pbb.2023.173659_bb0010","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.biopsych.2015.04.022","article-title":"Ketamine as a prophylactic against stress-induced depressive-like behavior","volume":"79","author":"Brachman","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"6579","key":"10.1016\/j.pbb.2023.173659_bb0015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.abl8615","article-title":"Structure-based discovery of nonhallucinogenic psychedelic analogs","volume":"375","author":"Cao","year":"2022","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.pbb.2023.173659_bb0020","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"15","key":"10.1016\/j.pbb.2023.173659_bb0025","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pbb.2023.173659_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109345","article-title":"Weapons of stress reduction: (R,S)-ketamine and its metabolites as prophylactics for the prevention of stress-induced psychiatric disorders","volume":"224","author":"Chen","year":"2023","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.pbb.2023.173659_bb0035","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pbb.2023.173659_bb0040","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neubiorev.2019.12.001","article-title":"Therapeutic use of serotoninergic hallucinogens: a review of the evidence and of the biological and psychological mechanisms","volume":"108","author":"Dos Santos","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"18","key":"10.1016\/j.pbb.2023.173659_bb0045","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.pbb.2023.173659_bb0050","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/pcn.12902","article-title":"Rapid-acting antidepressant ketamine, its metabolites and other candidates: a historical overview and future perspective","volume":"73","author":"Hashimoto","year":"2019","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pbb.2023.173659_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113935","article-title":"Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine","volume":"177","author":"Hashimoto","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pbb.2023.173659_bb0060","doi-asserted-by":"crossref","DOI":"10.1007\/s00406-023-01570-5","article-title":"Arketamine for cognitive impairment in psychiatric disorders","author":"Hashimoto","year":"2023","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"17","key":"10.1016\/j.pbb.2023.173659_bb0065","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022489118","article-title":"Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice","volume":"118","author":"Hesselgrave","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.pbb.2023.173659_bb0070","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1124\/pharmrev.120.000056","article-title":"Psychedelics in psychiatry: neuroplastic, immunomodulatory, and neurotransmitter mechanisms","volume":"73","author":"Inserra","year":"2021","journal-title":"Pharmacol. Rev."},{"issue":"11","key":"10.1016\/j.pbb.2023.173659_bb0075","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41593-022-01177-4","article-title":"The neural basis of psychedelic action","volume":"25","author":"Kwan","year":"2022","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.pbb.2023.173659_bb0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40263-021-00877-y","article-title":"Molecular mechanisms of psilocybin and implications for the treatment of depression","volume":"36","author":"Ling","year":"2022","journal-title":"CNS Drugs"},{"issue":"11","key":"10.1016\/j.pbb.2023.173659_bb0085","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.pbb.2023.173659_bb0090","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.neuron.2022.05.027","article-title":"The role of hippocampal KCNQ2 channel in antidepressant actions of ketamine","volume":"110","author":"Ma","year":"2022","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.pbb.2023.173659_bb0095","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41398-022-02192-6","article-title":"A key role of miR-132-5p in the prefrontal cortex for persistent prophylactic actions of (R)-ketamine in mice","volume":"212","author":"Ma","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pbb.2023.173659_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109250","article-title":"A role of microRNA-149 in the prefrontal cortex for prophylactic actions of (R)-ketamine in inflammation model","volume":"219","author":"Ma","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2023.173659_bb0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41398-022-01803-6","article-title":"Nuclear factor of activated T cells 4 in the prefrontal cortex is required for prophylactic actions of (R)-ketamine","volume":"12","author":"Ma","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pbb.2023.173659_bb0110","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jad.2022.08.087","article-title":"Effects of spleen nerve denervation on depression-like phenotype, systemic inflammation, and abnormal composition of gut microbiota in mice after administration of lipopolysaccharide: a role of brain-spleen axis","volume":"317","author":"Ma","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pbb.2023.173659_bb0115","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41398-023-02564-6","article-title":"A role of splenic heme biosynthesis pathway in the persistent prophylactic actions of arketamine in lipopolysaccharide-treated mice","volume":"13","author":"Ma","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pbb.2023.173659_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112238","article-title":"Prophylactic (R,S)-ketamine selectively protects against inflammatory stressors","volume":"378","author":"Mastrodonato","year":"2020","journal-title":"Behav. Brain Res."},{"issue":"6","key":"10.1016\/j.pbb.2023.173659_bb0125","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41573-022-00421-7","article-title":"The promises and perils of psychedelic pharmacology for psychiatry","volume":"21","author":"McClure-Begley","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.pbb.2023.173659_bb0130","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41593-023-01316-5","article-title":"Psychedelics promote plasticity by directly binding to BDNF receptor TrkB","volume":"26","author":"Moliner","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pbb.2023.173659_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109257","article-title":"Psychedelics therapeutics: what we know, what we think, and what we need to research","volume":"223","author":"Nutt","year":"2023","journal-title":"Neuropharmacology"},{"issue":"6649","key":"10.1016\/j.pbb.2023.173659_bb0140","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1126\/science.adj1031","article-title":"No trip needed for psychedelics to lift mood?","volume":"380","author":"O'Grady","year":"2023","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.pbb.2023.173659_bb0145","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1021\/acsptsci.0c00192","article-title":"The subjective effects of psychedelics may not be necessary for their enduring therapeutic effects","volume":"4","author":"Olson","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"10","key":"10.1016\/j.pbb.2023.173659_bb0150","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s11920-022-01361-0","article-title":"Psilocybin efficacy and mechanisms of action in major depressive disorder: a review","volume":"24","author":"Prouzeau","year":"2022","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.pbb.2023.173659_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2022.173500","article-title":"Rapid antidepressant-like effect of non-hallucinogenic psychedelic analog lisuride, but not hallucinogenic psychedelic DOI, in lipopolysaccharide-treated mice","volume":"222","author":"Qu","year":"2023","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2023.173659_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104762","article-title":"(R)-ketamine as prophylactic and therapeutic drug for neurological disorders: beyond depression","volume":"139","author":"Wang","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.pbb.2023.173659_bb0165","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41380-021-01121-1","article-title":"Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor","volume":"27","author":"Wei","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pbb.2023.173659_bb0170","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.brainresbull.2022.02.008","article-title":"Brain-spleen axis in health and diseases: a review and future perspective","volume":"182","author":"Wei","year":"2022","journal-title":"Brain Res. Bull."},{"issue":"9","key":"10.1016\/j.pbb.2023.173659_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.136","article-title":"R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects","volume":"5","author":"Yang","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"3","key":"10.1016\/j.pbb.2023.173659_bb0180","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/s41380-021-01377-7","article-title":"Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine","volume":"27","author":"Yao","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2023.173659_bb0185","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41398-020-00878-3","article-title":"A key role of the subdiaphragmatic vagus nerve in the depression-like phenotype and abnormal composition of gut microbiota in mice after lipopolysaccharide administration","volume":"10","author":"Zhang","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"10","key":"10.1016\/j.pbb.2023.173659_bb0190","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1007\/s00213-021-05889-6","article-title":"(R)-ketamine attenuates LPS-induced endotoxin-derived delirium through inhibition of neuroinflammation","volume":"238","author":"Zhang","year":"2021","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2023.173659_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109219","article-title":"Arketamine, a new rapid-acting antidepressant: a historical review and future directions","volume":"218","author":"Zhang","year":"2022","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2023.173659_bb0200","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41398-020-0733-x","article-title":"Essential role of microglial transforming growth factor-\u03b21 in antidepressant actions of (R)-ketamine and the novel antidepressant TGF-\u03b21","volume":"10","author":"Zhang","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"3","key":"10.1016\/j.pbb.2023.173659_bb0205","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00406-019-01092-z","article-title":"Splenic NKG2D confers resilience versus susceptibility in mice after chronic social defeat stress: beneficial effects of (R)-ketamine","volume":"271","author":"Zhang","year":"2021","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pbb.2023.173659_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109305","article-title":"Ketamine and its metabolites: potential as novel treatments for depression","volume":"222","author":"Zhang","year":"2023","journal-title":"Neuropharmacology"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305723001466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305723001466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T06:32:44Z","timestamp":1736317964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305723001466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":42,"alternative-id":["S0091305723001466"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2023.173659","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylactic effects of arketamine, but not hallucinogenic psychedelic DOI nor non-hallucinogenic psychedelic analog lisuride, in lipopolysaccharide-treated mice and mice exposed to chronic restrain stress","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2023.173659","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173659"}}